Bajaj Healthcare Limited has informed the Exchange regarding Re-appointment of Mr Pakshal Anil Jain as Whole-Time Director of the company w.e.f. June 30, 2026.
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bajaj Healthcare Limited has informed the stock exchange about the re-appointment of Mr Pakshal Anil Jain as Whole-Time Director of the company, effective from June 30, 2026. This is a continuation of his existing directorship role rather than a new appointment. The announcement confirms continuity on the board, though specific details on tenure length and revised remuneration terms have not been disclosed in this filing. Whole-time director re-appointments typically require shareholder approval under the Companies Act and SEBI LODR norms.
This is a routine corporate governance update with no change in management or business direction. No material impact expected on shareholders or stock price, though it signals board continuity.